Paradoxically, FGF21 levels are elevated in obesity [15] and obese mice treated with recombinant FGF21 have a blunted metabolic response to FGF21, which suggests that resistance to the actions of FGF21 may develop in obesity [16]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.